Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biotricity Inc (NQ: BTCY )

1.583 -0.167 (-9.54%)
Streaming Delayed Price Updated: 11:36 AM EDT, Jul 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,840
Open 1.710
Bid (Size) 1.580 (2)
Ask (Size) 1.620 (9)
Prev. Close 1.750
Today's Range 1.531 - 1.710
52wk Range 0.9500 - 5.300
Shares Outstanding 49,810,322
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga

Performance

YTD
-60.72%
-60.72%
1 Month
+20.85%
+20.85%
3 Month
-31.47%
-31.47%
6 Month
-60.72%
-60.72%
1 Year
-45.60%
-45.60%

More News

Read More
Biotricity: Dividend Insights
Via Benzinga
Biotricity to Join Russell Microcap(R) Index
From Biotricity, Inc.
Via AccessWire
37 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
77 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th
From Biotricity, Inc.
Via AccessWire
Biotricity Issues Shareholder Update
From Biotricity, Inc.
Via AccessWire
Exposures COVID-19
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022
From Biotricity, Inc.
Via AccessWire
Exposures Product Safety
71 Biggest Movers From Yesterday
Via Benzinga
Biotricity Inc. (NASDAQ: BTCY) Featured in Virtual Coverage of the 34th Annual Roth Conference
Via Investor Brand Network
Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022
From Biotricity, Inc.
Via AccessWire
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022
Via Benzinga
Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th
From Biotricity, Inc.
Via AccessWire
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device
From Biotricity, Inc.
Via AccessWire
Exposures Product Safety
Biotricity Releases Fiscal 2022 Third Quarter Financial Results
From Biotricity, Inc.
Via AccessWire
Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022
From Biotricity, Inc.
Via AccessWire
Exposures Product Safety
Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device
From Biotricity, Inc.
Via AccessWire
Exposures Product Safety
Earnings Scheduled For February 14, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Biotricity Expands Distribution of New Bioheart Device on Amazon.com
From Biotricity, Inc.
Via AccessWire
Biotricity Completes $12 Million Non-Dilutive Debt Financing
From Biotricity, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.